Epstein Secrets

l infirmity can be easily excised." Justice Elena Kagan "said it was strange to bring a lawsuit after Co

opinion he wrote last term — created a strong presumption that a law should be saved if the constitutional infirmity can be easily excised." Justice Elena Kagan "said it was strange to bring a lawsuit after Congress had gotten rid of the penalty for noncompliance." USA Today <https://www.usatoday.com/story/

t outside the country. The AP <https://apnews.corn/article/intemational-news-virus-outbreak-moscow-russia- e669532c8689fb0327ecd19b3f5d4ad5> (11/11, Litvinova) reports, "Developers of Sputnik V, Russia's experimental COVID-19 vaccine, announced Wednesday that early, interim data from a large trial suggests

l infirmity can be easily excised." Justice Elena Kagan "said it was strange to bring a lawsuit after Co

opinion he wrote last term - created a strong presumption that a law should be saved if the constitutional infirmity can be easily excised." Justice Elena Kagan "said it was strange to bring a lawsuit after Congress had gotten rid of the penalty for noncompliance." USA Today (11/10, Wolf, 10.31M) also says

y effective," but questions remain about whether the information can be trusted or if the vaccine will make it outside the country. The AP (11/11, Litvinova) reports, "Developers of Sputnik V, Russia's experimental COVID-19 vaccine, announced Wednesday that early, interim data from a large trial suggests

l infirmity can be easily excised." Justice Elena Kagan "said it was strange to bring a lawsuit after Co

opinion he wrote last term - created a strong presumption that a law should be saved if the constitutional infirmity can be easily excised." Justice Elena Kagan "said it was strange to bring a lawsuit after Congress had gotten rid of the penalty for noncompliance." USA Today (11/10, Wolf, 10.31M) also says

y effective," but questions remain about whether the information can be trusted or if the vaccine will make it outside the country. The AP (11/11, Litvinova) reports, "Developers of Sputnik V, Russia's experimental COVID-19 vaccine, announced Wednesday that early, interim data from a large trial suggests